Development of an HPTLC-based diagnostic method for invasive aspergillosis

Biomedical Chromatography

Volumn 24, Issue 8, 2010, Pages 887-892

  Puri, Alka ^a   Ahmad, Ajaz ^a   Panda, Bibhu Prasad ^a  

^a HAMDARD UNIVERSITY   (India)

Author keywords

Aspergillus; Diagnostic methods; Gliotoxin; HPTLC; Invasive aspergillosis

Indexed keywords

ABSORBANCE; ALUMINUM COATINGS; BODY FLUIDS; CHLORINE COMPOUNDS; CHROMATOGRAPHIC ANALYSIS; COST EFFECTIVENESS; DIAGNOSIS; SILICA GEL; THIN LAYER CHROMATOGRAPHY;

ABSORBANCES; CHROMATOGRAPHIC METHODS; DENSITOMETRIC ANALYSIS; DIAGNOSTIC METHODS; GLIOTOXIN; HIGH-PERFORMANCE THIN-LAYER CHROMATOGRAPHIC; INVASIVE ASPERGILLOSIS; PERFORMANCE; SERUM SAMPLES; THIN LAYERS;

ASPERGILLUS;

CHLOROFORM; GLIOTOXIN; MYCOTOXIN;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CALIBRATION; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; EXTRACTION; FUNGUS CULTURE; FUNGUS ISOLATION; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; HUMAN; NONHUMAN; SERUM; TOXIN ANALYSIS; BLOOD; CHEMISTRY; DIAGNOSTIC USE; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGY; PROCEDURES; SENSITIVITY AND SPECIFICITY; THIN LAYER CHROMATOGRAPHY;

ASPERGILLUS;

ASPERGILLOSIS; ASPERGILLUS; CHROMATOGRAPHY, THIN LAYER; DIAGNOSTIC TECHNIQUES AND PROCEDURES; GLIOTOXIN; HUMANS; SENSITIVITY AND SPECIFICITY;

EID: 77954735618     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1382     Document Type: Article

References (36)

1. Ahmad S, Rizwan M, Parween R, Mujeed M and Aquil, M. A validated stability-indicating TLC method for determination of forskolin in crude drug and pharmaceutical dosage form. Chromatographia 2008; 67: 441-447.
2. Ali J, Akhtar N, Sultana Y, Baboot S and Ahmad S. Thin-layer chromatographic analysis of psoralen in babchi (Psoralea corylifolia) oil. Acta chromatographica 2008; 2: 277-282.
3. Bauer J, Gareis M, Bott A and Gedek B. Isolation of a mycotoxin (gliotoxin) from a bovine udder infected with Aspergillus fumigatus. Journal of Medical and Veterinary Mycology 1989; 27: 45-50. (Pubitemid 19153215)
4. Belkacemi L, Barton RC, Hopwood V and Evans EG. Determination of optimum growth conditions for gliotoxin production by Aspergillus fumigatus and development of a novel method for gliotoxin detection. Journal of Medical and Veterinary Mycology 1999; 37: 227-233.
5. Bondy GS and Pestka JJ. Immunomodulation by fungal toxins. Journal of Toxicology and Environmental Health 2000; 3: 109-143.
6. Denning DW, Riniotis K, Dobrashian R and Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change and review. Clinical Infectious Disease 2003; 37(suppl 3): S265-280.
7. Fischer G, Muller T, Schwalbe R, Ostrowski R and Dott W. Exposure to airborne fungi, MVOC and mycotoxins in biowaste-handling facilities. International Journal of Hygiene and Environmental Health 2000; 203: 97-104.
8. Fitzpatrick LR, Wang J and Le T. In vitro and in vivo effects of gliotoxin, a fungal metabolite: efficacy against dextran sodium sulfate-induced colitis in rats. Digestive Disease Sciences 2000; 45: 2327-2336.
9. Hope WW, Walsh TJ and Denning DW. Laboratory diagnosis of invasive aspergillosis. Lancet Infectious Diseases 2005; 5: 609-22.
10. Kosalec I and Pepeljnjak S. The chemistry and biological effects of gliotoxin. Archives of Industrial Hygiene and Toxicology 2004; 55: 313-320.
11. Kosalec I and Pepeljnjak S. Mycotoxigenicity of clinical and environmental Aspergillus fumigatus and A. flavus isolates. Acta Pharmaceutica 2005; 55: 365-375. (Pubitemid 41820298)
12. Kosalec I, Pepeljnjak S and Jandrlic M. Influence of media and temperature on gliotoxin production in Aspergillus fumigatus strains. Archives of Industrial Hygiene and Toxicology 2005; 56: 269-273. (Pubitemid 41208345)
13. Kupfahl C, Geginat G and Hof H. Gliotoxin mediated suppression of innate and adaptive immune functions directed against Listeria monocytogenes. Medical Mycology 2006; 44: 591-599. (Pubitemid 44650508)
14. Kupfahl C, Ruppert T, Dietz A, Geginat G and Hof H. Candida species fail to produce the immunosuppressive secondary metabolite gliotoxin in vitro. FEMS Yeast Research 2007; 7: 986-992. (Pubitemid 47256364)
15. Kupfahl C, Michalka A, Florl CL, Fischer G, Haase G, Ruppert T, Geginat G and Hof H. Gliotoxin production by clinical and environmental Aspergillus fumigatus. International Journal of Medical Microbiology 2008; 298: 319-327. (Pubitemid 351318358)
16. Latge JP, Kobayashi H, Debeaupuis JP, Diaquin M, Sarfati J, Wieruszeski JM, Parra E, Bouchara JP and Fournet B. Chemical and immunological characterization of the extracellular galactomannan of Aspergillus fumigatus. Infection and Immunity 1994; 62: 5424-5433.
17. Lewis RE, Chi J, Wiederhold, NP, Kontoyiannis DP, Han X and Prince RA. Detection of gliotoxin, an immunologically active metabolite secreted by Aspergillus fumigatus, in animals and humans with invasive aspergillosis. Book of Abstracts of 43rd ICAAC (Interscience Conference on Antimicrobial Agents and Chemotherapy), Chicago, 14-17 September, 2003.
18. Lewis RE, Wiederhold NP, Lionakis MS, Prince RA and Kontoyiannis DP. Frequency and species distribution of Gliotoxin-producing Aspergillus isolates recovered from patients at a tertiary-care cancer center. Journal of Clinical Microbiology 2005a; 43: 6120-6122.
19. Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP and Prince RA. Detection of gliotoxin in experimental and human aspergillosis. Infection and Immunity 2005b; 73: 635-637. (Pubitemid 40041162)
20. Loeffler J, Hebart H, Cox P, Flues N, Schumacher U and Einsele, H. Nucleic acid sequence-based amplification of Aspergillus RNA in blood samples. Journal of Clinical Microbiology 2001; 39: 1626-1629. (Pubitemid 32275480)
21. 558 in the activation of the human neutrophil NADPH oxidase. Infection and Immunity 2005; 73: 235-244.
22. Richard JL and DeBey MC. Production of gliotoxin during the pathogenic state in turkey poults by Aspergillus fumigatus. Fresenius Mycopathologia 1995; 129: 111-115.
23. Richard JL, Dvorak TJ and Ross PF. Natural occurrence of gliotoxin in turkeys infected with Aspergillus fumigatus. Fresenius Mycopathologia 1996; 134: 167-170.
24. Rylander R, Norrhall M, Engdahl U, Tunsater A and Holt PG. Airways inflammation, atopy, and (1 → 3)-beta-D-glucan exposures in two schools. American Journal of Respiratory and Critical Care Medicine 1998; 158: 1685-1687.
25. Sarfati J, Monod M, Recco P, Sulahian A, Pinel C, CandolfiE, Fontaine T, Debeaupuis JP, Tabouret M, Latge JP. Recombinant antigens as diagnostic markers for aspergillosis. Diagnostic Microbiology and Infectious Disease 2006; 55: 279-291.
26. Stanzani M, Orciuolo E, Lewis R, Kontoyiannis DP, Martins SL, St John LS and Komanduri KV. Aspergillus fumigatus suppresses the human cellular immune response via gliotoxin-mediated apoptosis of monocytes. Blood 2005; 105: 2258-2265. (Pubitemid 40387017)
27. Strandberg GW. D-mannitol metabolism by Aspergillus candidus. Journal of Bacteriology 1969; 97: 1305-1309.
28. Sutton P, Beaver J and Waring P. Evidence that gliotoxin enhances lymphocyte activation and induces apoptosis by effects on cyclic AMP levels. Biochemical Pharmacology 1995; 50: 2009-2014. (Pubitemid 26089926)
29. Tarrand JJ, Lichterfeld M, Warraich I, Luna M, Han XY, May GS and Kontoyiannis DP. Diagnosis of invasive septate mold infections. American Journal of Clinical Pathology 2003; 119: 854-58.
30. Tomee JF and Kauffman HF. Putative virulence factors of Aspergillus fumigatus. Clinical and Experimental Allergy 2000; 30: 476-484.
31. Vanhee LM, Symoens F, Nelis HJ, Coenye T. Microsatellite typing of Aspergillus fumigatus isolates recovered from deep organ samples of patients with invasive aspergillosis. Diagnostic Microbiology and Infectious Disease 2008; 62: 96-98.
32. Waring P and Beaver J. Gliotoxin and related epipolythiodioxopiperazines. General Pharmacology 1996; 27: 1311-1316.
33. Wong B, Brauer KL, Tsai RR, Jayasimhulu K. Increased amounts of the Aspergillus metabolite D-mannitol in tissue and serum of rats with experimental aspergillosis. Journal of Infectious Diseases 1989; 160: 95-103. (Pubitemid 19162998)
34. Yoo JH, Choi JH, Choi SM, Lee DG, Shin WS, Min WS and Kim CC. Application of nucleic acid sequence-based amplification for diagnosis of and monitoring the clinical course of invasive aspergillosis in patients with hematologic diseases. Clinical Infectious Diseases 2005; 40: 392-398.
35. Yoo JH, Choi SM, Choi JH, Kwon EY, Park C and Shin WS. Construction of internal control for the quantitative assay of Aspergillus fumigatus using real-time nucleic acid sequence-based amplification. Diagnostic Microbiology and Infectious Disease 2008; 60: 121-124. (Pubitemid 350235173)
36. Young RC and Bennett JE. Invasive aspergillosis - absence of detectable antibody response. American Review of Respiratory Disease 1971; 104: 710-716.